MedTrace Logo

Irish Programme for Stratified Prostate Cancer Therapy

NCT03162003 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2025-07-08

No results posted yet for this study

Summary

The purpose of the trial is to investigate new clinical tests that could predict what treatments work best for certain patients with advanced prostate cancer by identifying markers and indicators present in blood and tissue which correlate with treatment response.

Conditions

Sponsors & Collaborators

  • Cancer Trials Ireland

    lead NETWORK

Principal Investigators

  • Prof Ray McDermott · SVUH, AMNCH

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2020-08-31
Completion
2020-10-08

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03162003 on ClinicalTrials.gov